You are here

ORIC Pharmaceuticals

Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more

MedCity News

Mon, 03/28/22 - 10:17 am

Aligos Therapeutics

Vallon Pharmaceuticals

ORIC Pharmaceuticals

Neurana Pharmaceuticals

What pandemic? Biotech floats break records

EP Vantage

Wed, 07/8/20 - 10:37 am

ADC Therapeutics

Applied Molecular Transport

Avidity Biosciences

Ayala Pharmaceuticals

Forma Therapeutics

Fusion Pharmaceuticals

Hyloris Pharmaceuticals

ORIC Pharmaceuticals

Pliant Therapeutics

Repare Therapeutics

Will Last Week's Biotech IPO Outperform in a Recession?

Motley Fool

Tue, 04/28/20 - 10:46 am

ORIC Pharmaceuticals

ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers

Xconomy

Mon, 03/2/20 - 11:14 pm

ORIC Pharmaceuticals

Can Lightning Strike Three Times? Prostate Cancer Drug Developer Gets $53M to Find Out

Forbes

Wed, 12/2/15 - 09:32 am

prostate cancer

ORIC Pharmaceuticals